Ex- Viropharma Linkedin Page

Ex- Viropharma Linkedin Page company information, Employees & Contact Information

Retired from Pharmaceutical Industry

Company Details

Employees
81
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Looking for a particular Ex- Viropharma Linkedin Page employee's phone or email?

Ex- Viropharma Linkedin Page Questions

News

PRESS RELEASE - SEC.gov

PRESS RELEASE SEC.gov

ViroPharma Will Buy DuoCort for $33.6M Up Front if EU-Filed Hydrocortisone Drug Is Approved - Genetic Engineering and Biotechnology News

ViroPharma Will Buy DuoCort for $33.6M Up Front if EU-Filed Hydrocortisone Drug Is Approved Genetic Engineering and Biotechnology News

$4.2 Billion Deal Highlights Drug Profits From Rare Diseases : Shots - Health News - NPR

$4.2 Billion Deal Highlights Drug Profits From Rare Diseases : Shots - Health News NPR

Shire buys US drug firm ViroPharma for $4.2bn - BBC

Shire buys US drug firm ViroPharma for $4.2bn BBC

Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human]) - PR Newswire

Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human]) PR Newswire

Shire acquires ViroPharma for $4.2bn - Financier Worldwide

Shire acquires ViroPharma for $4.2bn Financier Worldwide

ViroPharma shares soar after deal with Shire - USA Today

ViroPharma shares soar after deal with Shire USA Today

Shire buying Exton-based ViroPharma for $4.2B - Inquirer.com

Shire buying Exton-based ViroPharma for $4.2B Inquirer.com

Schering-Plough in Licensing Move With ViroPharma - TheStreet

Schering-Plough in Licensing Move With ViroPharma TheStreet

Shire Buys ViroPharma for $4.2M, Expanding Rare Disease Holdings - Genetic Engineering and Biotechnology News

Shire Buys ViroPharma for $4.2M, Expanding Rare Disease Holdings Genetic Engineering and Biotechnology News

ViroPharma Licenses Halozyme’s Hyaluronidase for $9M to Develop Subcutaneous Cinryze - Genetic Engineering and Biotechnology News

ViroPharma Licenses Halozyme’s Hyaluronidase for $9M to Develop Subcutaneous Cinryze Genetic Engineering and Biotechnology News

Shire Acquires Meritage Pharma for Up-to-$245M - Genetic Engineering and Biotechnology News

Shire Acquires Meritage Pharma for Up-to-$245M Genetic Engineering and Biotechnology News

Top Ex- Viropharma Linkedin Page Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant